Yu-Chung (Harry) Huang

Yu-Chung (Harry) Huang

Takeda Pharmaceutical Company Limited - Osaka / Japan
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4447709
武田薬品工業株式会社
person_outline Yu-Chung (Harry) Huang's MOST POPULAR ARTICLES
1-) BRAF mutation is a prognostic biomarker for colorectal liver metastasectomyHW Teng, YC Huang, JK Lin, WS Chen, TC Lin, JK Jiang, CC Yen, AFY Li, ...Journal of surgical oncology 106 (2), 123-129, 2012872012
2-) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II diseaseYC Huang, JK Lin, WS Chen, TC Lin, SH Yang, JK Jiang, SC Chang, ...Journal of cancer research and clinical oncology 137 (2), 211-220, 2011622011
3-) Comprehensive mapping of pluripotent stem cell metabolism using dynamic genome-scale network modelingS Chandrasekaran, J Zhang, Z Sun, L Zhang, CA Ross, YC Huang, ...Cell reports 21 (10), 2965-2977, 2017592017
4-) Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphomaYL Lai, JK Lin, WY Liang, YC Huang, SC ChangJournal of surgical oncology 104 (3), 265-268, 2011552011
5-) Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphomaYC Huang, CJ Liu, CY Liu, JT Pai, YC Hong, HW Teng, LT Hsiao, ...Annals of hematology 90, 1145-1151, 2011512011